Pneumonia

MPR Weekly Dose Podcast Episode 45

It’s been an important week with big developments in potential COVID-19 vaccines; News on how steroid therapy may help some COVID patients; There’s results from the Actemra trial in COVID pneumonia patients; News that sputum samples may be just as effective as nasopharyngeal samples for detecting SARS-CVv-2; And researchers have linked vaccination to reduced risks of Alzheimer disease.

Shedding Light on the Importance of HPV Vaccination

20-Valent Pneumococcal Conjugate Vaccine Safe, Immunogenic in Phase 3 Trial

Pfizer announced topline data from one of its phase 3 studies for 20-valent pneumococcal conjugate vaccine (20vPnC) for the prevention of invasive disease and pneumonia caused by Streptococcus pneumoniae serotypes in adults aged ≥18 years. The randomized, double-blind trial included 3880 adults aged ≥18 years who were pneumococcal vaccine-naive. The trial was designed to compare…